Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
503 participants
OBSERVATIONAL
2020-02-03
2021-03-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Remote Digital Physiologic Data Collection in Cancer: An MSK Registry Protocol
NCT05390827
Community Cancer Centers Pilot Patient Survey
NCT00786656
Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom
NCT00757614
Detecting Cancers Earlier Through Elective Plasma-based CancerSEEK Testing
NCT04213326
Rare Tumors and Cancer Predisposition in Individuals and Families
NCT05350761
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
To enhance understanding of the comprehensive psychosocial and medical needs of cancer survivors and caregivers in rural northwest North Carolina, focusing on their health needs, psychosocial concerns, perceived needs related to cancer and survivorship care, access/barriers to care, and knowledge/perceptions of clinical research using focus groups and semi-structured interviews. This aim is hypothesis-generating.
To document rural cancer patient/survivors' reports of: a) health behaviors; b) psychosocial needs; c) current health-related information and supportive care needs; d) barriers to care; e) symptoms and health-related quality of life using a quantitative survey
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Semi-Structured Interview
Participants will choose to participant in an individual in-depth interview to be conducted by investigators to gain information about the participant's background, cancer status and treatment.
No interventions assigned to this group
Focus Groups
Participants may choose to participate in one of three focus groups of no more than 10 participants in each group to to gain information about the participant's background, cancer status and treatment.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Currently residing in one of the 6 priority counties in northwest North Carolina (Alleghany, Ashe, Avery, Mitchell, Stokes, Surry, Watauga, or Wilkes) or in a rural area in North Carolina as defined by a rural-urban commuting area (RUCA) code of 4-10.
* Ability and willingness to attend a one-time focus group or interview and/or complete a one-time study survey
* Age greater than 18 years.
Providers:
* Healthcare provider (e.g. primary care, oncology or other specialty, allied health) with knowledge of the needs of adult cancer survivors who are currently working in one of the priority counties in Northwest North Carolina (Alleghany, Ashe, Avery, Mitchell, Stokes, Surry, Watauga, or Wilkes)
* Ability and willingness to attend a one-time interview
Exclusion Criteria
* Unwilling to participate in the study
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
Wake Forest University Health Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kathryn Weaver, MPH, PhD
Role: PRINCIPAL_INVESTIGATOR
Wake Forest University Health Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Wake Forest Baptist Comprehensive Cancer Center
Winston-Salem, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
WFBCCC 04219
Identifier Type: OTHER
Identifier Source: secondary_id
NCI-2019-01751
Identifier Type: OTHER
Identifier Source: secondary_id
IRB00056939
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.